These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15265137)

  • 1. Splenic rupture after granulocyte-colony-stimulating factor mobilization in a peripheral blood progenitor cell donor.
    Balaguer H; Galmes A; Ventayol G; Bargay J; Besalduch J
    Transfusion; 2004 Aug; 44(8):1260-1. PubMed ID: 15265137
    [No Abstract]   [Full Text] [Related]  

  • 2. Splenic rupture in a patient with plasma cell myeloma following G-CSF/GM-CSF administration for stem cell transplantation and review of the literature.
    Veerappan R; Morrison M; Williams S; Variakojis D
    Bone Marrow Transplant; 2007 Aug; 40(4):361-4. PubMed ID: 17563733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous splenic rupture in a healthy allogeneic donor of peripheral-blood stem cell following the administration of granulocyte colony-stimulating factor (g-csf). A case report and review of the literature.
    Nuamah NM; Goker H; Kilic YA; Dagmoura H; Cakmak A
    Haematologica; 2006 May; 91(5 Suppl):ECR08. PubMed ID: 16709516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splenic rupture in a parental donor undergoing peripheral blood progenitor cell mobilization.
    Dincer AP; Gottschall J; Margolis DA
    J Pediatr Hematol Oncol; 2004 Nov; 26(11):761-3. PubMed ID: 15543014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythema nodosum secondary to granulocyte colony-stimulating factor in a patient with Hodgkin lymphoma during CD34+ cell mobilization for autologous peripheral blood stem cell transplantation: a dose-mediated effect.
    George S; George B; Gorak E
    Biol Blood Marrow Transplant; 2005 Oct; 11(10):816-7. PubMed ID: 16182183
    [No Abstract]   [Full Text] [Related]  

  • 6. Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry.
    de la Rubia J; de Arriba F; Arbona C; Pascual MJ; Zamora C; Insunza A; Martínez D; Paniagua C; Díaz MA; Sanz MA
    Haematologica; 2008 May; 93(5):735-40. PubMed ID: 18387976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute lung Injury in a healthy donor during mobilization of peripheral blood stem cells using granulocyte-colony stimulating factor alone.
    Arimura K; Inoue H; Kukita T; Matsushita K; Akimot M; Kawamata N; Yamaguchi A; Kawada H; Ozak A; Arima N; Te C
    Haematologica; 2005 Mar; 90(3):ECR10. PubMed ID: 15753051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe autoimmune hyperthyroidism after donation of growth factor-primed allogeneic peripheral blood progenitor cells.
    Kroschinsky F; Hundertmark J; Mauersberger S; Hermes M; Poppe-Thiede K; Rutt C; Ehninger G; Schuster P
    Haematologica; 2004 Apr; 89(4):ECR05. PubMed ID: 15075097
    [No Abstract]   [Full Text] [Related]  

  • 9. Rhabdomyolysis in allogeneic peripheral blood stem cell donors.
    Schanz J; Wolf C; Koehler M; Maas JH; Meyer M; Neumeyer H; Legler TJ; Wulf G; Glass B; Truemper L; Riggert J
    Vox Sang; 2004 May; 86(4):263-5. PubMed ID: 15144532
    [No Abstract]   [Full Text] [Related]  

  • 10. Transient respiratory disturbance by granulocyte-colony-stimulating factor administration in healthy donors of allogeneic peripheral blood progenitor cell transplantation.
    Yoshida I; Matsuo K; Teshima T; Hashimoto D; Tanimoto Y; Harada M; Tanimoto M
    Transfusion; 2006 Feb; 46(2):186-92. PubMed ID: 16441593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is G-CSF-mobilized peripheral stem cell harvest harmful?
    Donadieu J
    Pediatr Blood Cancer; 2007 May; 48(5):594-5; author reply 595-7. PubMed ID: 16767714
    [No Abstract]   [Full Text] [Related]  

  • 12. A rare but severe complication of filgrastim in a healthy donor: splenic rupture.
    Akyol G; Pala C; Yildirim A; Keklika M; Demir K; Dortdudak S; Sivgin S; Kaynar L; Esera B; Unal A; Cetin M
    Transfus Apher Sci; 2014 Feb; 50(1):53-5. PubMed ID: 24360843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splenic rupture in a plasma cell leukemia, mobilized with G-CSF for autologous stem cell transplant.
    Funes C; Garcia-Candel F; Majado MJ; González-García C; Bas A; Salido E; Moraleda JM; Morales A
    J Clin Apher; 2010; 25(4):223-5. PubMed ID: 20818717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute gouty arthritis following recombinant human granulocyte colony-stimulating factor therapy in an allogeneic blood stem cell donor.
    Spitzer T; McAfee S; Poliquin C; Colby C
    Bone Marrow Transplant; 1998 May; 21(9):966-7. PubMed ID: 9613796
    [No Abstract]   [Full Text] [Related]  

  • 15. Peripheral blood progenitor cell mobilization with intermediate-dose cyclophosphamide, sequential granulocyte-macrophage-colony-stimulating factor and granulocyte-colony-stimulating factor, and scheduled commencement of leukapheresis in 225 patients undergoing autologous transplantation.
    Bashey A; Donohue M; Liu L; Medina B; Corringham S; Ihasz A; Carrier E; Castro JE; Holman PR; Xu R; Law P; Ball ED; Lane TA
    Transfusion; 2007 Nov; 47(11):2153-60. PubMed ID: 17958545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous rupture of spleen during periferal blood stem cell mobilization in a patient with breast cancer.
    Pitini V; Ciccolo A; Arrigo C; Aloi G; Micali C; La Torre F
    Haematologica; 2000 May; 85(5):559-60. PubMed ID: 10800183
    [No Abstract]   [Full Text] [Related]  

  • 17. Erythema exsudativum multiforme induced by granulocyte colony-stimulating factor in an allogeneic peripheral blood stem cell donor.
    Mori T; Sato N; Watanabe R; Okamoto S; Ikeda Y
    Bone Marrow Transplant; 2000 Jul; 26(2):239-40. PubMed ID: 10918440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project.
    Tigue CC; McKoy JM; Evens AM; Trifilio SM; Tallman MS; Bennett CL
    Bone Marrow Transplant; 2007 Aug; 40(3):185-92. PubMed ID: 17563736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor.
    Watanabe H; Watanabe T; Suzuya H; Wakata Y; Kaneko M; Onishi T; Okamoto Y; Abe T; Kawano Y; Kagami S; Takaue Y
    Bone Marrow Transplant; 2006 Apr; 37(7):661-8. PubMed ID: 16489358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial.
    Engelmann MG; Theiss HD; Hennig-Theiss C; Huber A; Wintersperger BJ; Werle-Ruedinger AE; Schoenberg SO; Steinbeck G; Franz WM
    J Am Coll Cardiol; 2006 Oct; 48(8):1712-21. PubMed ID: 17045910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.